US5320960A
(en)
*
|
1992-04-03 |
1994-06-14 |
Genencor International, Inc. |
Method of preparing solution enriched in xylanase using low molecular weight alcohol, organic salt and inorganic salt
|
US5298405A
(en)
*
|
1986-04-30 |
1994-03-29 |
Alko Limited |
Enzyme preparations with recombinantly-altered cellulose profiles and methods for their production
|
US5780292A
(en)
*
|
1987-04-29 |
1998-07-14 |
Alko Group Ltd. |
Production of phytate degrading enzymes in trichoderma
|
US5610034A
(en)
*
|
1987-04-29 |
1997-03-11 |
Alko Group Ltd. |
Immunoglobulin production by trichoderma
|
US5258287A
(en)
*
|
1988-03-22 |
1993-11-02 |
Genentech, Inc. |
DNA encoding and methods of production of insulin-like growth factor binding protein BP53
|
JP2728531B2
(ja)
*
|
1988-03-24 |
1998-03-18 |
ノボ ノルディスク アクティーゼルスカブ |
セルラーゼ調製品
|
CA1333777C
(en)
*
|
1988-07-01 |
1995-01-03 |
Randy M. Berka |
Aspartic proteinase deficient filamentous fungi
|
CA1341226C
(en)
*
|
1988-08-16 |
2001-05-01 |
Wim Van Hartingsveldt |
Gene replacement as a tool for the construction of aspergillus strains
|
FR2649120B1
(fr)
*
|
1989-06-30 |
1994-01-28 |
Cayla |
Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
|
US5120463A
(en)
*
|
1989-10-19 |
1992-06-09 |
Genencor International, Inc. |
Degradation resistant detergent compositions based on cellulase enzymes
|
US5688290A
(en)
*
|
1989-10-19 |
1997-11-18 |
Genencor International, Inc. |
Degradation resistant detergent compositions based on cellulase enzymes
|
US5837515A
(en)
*
|
1990-05-16 |
1998-11-17 |
Alko-Yhtiot Oy |
Enzyme preparations and methods for their production
|
FI903443A
(fi)
*
|
1990-07-06 |
1992-01-07 |
Valtion Teknillinen |
Framstaellning av lackas genom rekombinantorganismer.
|
EP0539395A1
(en)
*
|
1990-07-16 |
1993-05-05 |
Alko Group Ltd. |
IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA)
|
US5246853A
(en)
*
|
1990-10-05 |
1993-09-21 |
Genencor International, Inc. |
Method for treating cotton-containing fabric with a cellulase composition containing endoglucanase components and which composition is free of exo-cellobiohydrolase I
|
US5650322A
(en)
*
|
1990-10-05 |
1997-07-22 |
Genencor International, Inc. |
Methods for stonewashing fabrics using endoglucanases
|
US5290474A
(en)
*
|
1990-10-05 |
1994-03-01 |
Genencor International, Inc. |
Detergent composition for treating cotton-containing fabrics containing a surfactant and a cellulase composition containing endolucanase III from trichoderma ssp
|
CA2093422C
(en)
*
|
1990-10-05 |
2001-04-03 |
|
DETERGENT COMPOSITIONS CONTAINING LOW CBH I CONTENT CELLULASE COMPOSITIONS
|
US5654193A
(en)
*
|
1990-10-05 |
1997-08-05 |
Genencor International, Inc. |
Methods for treating cotton containing fabrics with cellulase
|
US5525507A
(en)
*
|
1990-10-05 |
1996-06-11 |
Genencor International, Inc. |
Methods for treating cotton-containing fabric with cellulase composition containing endoglucanase component and which is free of all CBH I component
|
US5328841A
(en)
*
|
1990-10-05 |
1994-07-12 |
Genencor International, Inc. |
Methods for isolating EG III cellulase component and EG III cellulase in polyethylene glycol using inorganic salt and polyethylene glycol
|
ES2322032T3
(es)
*
|
1990-12-10 |
2009-06-16 |
Genencor Int |
Sacrificacion mejorada de celulosa por clonacion y amplificacion del gen de beta-glucosidasa de trichoderma reesei.
|
JPH06505873A
(ja)
*
|
1991-03-22 |
1994-07-07 |
ジスト―ブロカデス ベスローテン フェンノートシャップ |
キモシンの製造方法
|
AU678356B2
(en)
*
|
1992-05-01 |
1997-05-29 |
Genencor International, Inc. |
Methods for treating cotton-containing fabrics with CBH I enriched cellulase
|
EP0655890B1
(en)
*
|
1992-07-31 |
2005-01-26 |
AB Enzymes GmbH |
Recombinant cells, dna constructs, vectors and methods for expression phytate degrading enzymes in desired ratios
|
US5665585A
(en)
*
|
1992-09-03 |
1997-09-09 |
Alko-Yhiot Oy |
Recombinant production of glucoamylase P in trichoderma
|
GB9400623D0
(en)
*
|
1994-01-14 |
1994-03-09 |
Univ Leeds |
Exploitation of the cellulase enzyme complex of neurospora
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US7816129B2
(en)
|
1994-07-29 |
2010-10-19 |
Ab Enzymes Gmbh |
Production and secretion of proteins of bacterial origin in filamentous fungi
|
US5834251A
(en)
*
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
US5700686A
(en)
*
|
1995-06-06 |
1997-12-23 |
Iogen Corporation |
Protease-treated and purified cellulase compositions and methods for reducing backstaining during enzymatic stonewashing
|
EP1382679A3
(en)
|
1995-09-08 |
2004-11-10 |
Genentech, Inc. |
Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists
|
JP2000503204A
(ja)
|
1996-01-08 |
2000-03-21 |
ジェネンテック インコーポレーテッド |
Wsxレセプター及びリガンド類
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US6100076A
(en)
|
1997-01-31 |
2000-08-08 |
Genentech, Inc. |
O-fucosyltransferase
|
AU729158B2
(en)
|
1997-01-31 |
2001-01-25 |
Genentech Inc. |
O-fucosyltransferase
|
ES2256935T3
(es)
|
1997-04-07 |
2006-07-16 |
Genentech, Inc. |
Anticuerpos humanizadores y procedimiento para producirlos.
|
AU743758B2
(en)
|
1997-04-07 |
2002-02-07 |
Genentech Inc. |
Anti-VEGF antibodies
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
DE69840508D1
(de)
|
1997-08-27 |
2009-03-12 |
Childrens Hosp Medical Center |
Molekular-mimetika von meningokokkus b epitopen
|
EP1029046B1
(en)
|
1997-10-29 |
2008-09-24 |
Genentech, Inc. |
Wnt-1 inducible genes
|
AU1288399A
(en)
|
1997-10-29 |
1999-05-17 |
Genentech Inc. |
Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
|
EP2050762A3
(en)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Human cornichon-like protein and nucleic acids encoding it
|
ATE365800T1
(de)
|
1998-05-15 |
2007-07-15 |
Genentech Inc |
Therapeutische verwendungen von il-17 homologe polypeptide
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
EP1865061A3
(en)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
JP2002527066A
(ja)
|
1998-10-15 |
2002-08-27 |
カイロン コーポレイション |
転移性乳癌および結腸癌調節遺伝子
|
SI1135498T1
(sl)
|
1998-11-18 |
2008-06-30 |
Genentech Inc |
Variante protitelesa z višjo vezavno afiniteto vprimerjavi z izvirnimi protitelesi
|
PT1141331E
(pt)
|
1998-12-16 |
2008-12-22 |
Novartis Vaccines & Diagnostic |
Quinase dependente de ciclina humana (hpnqalre)
|
EP1484338B1
(en)
|
1998-12-22 |
2007-02-07 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
EP1141024B1
(en)
|
1999-01-15 |
2018-08-08 |
Genentech, Inc. |
POLYPEPTIDE COMPRISING A VARIANT HUMAN IgG1 Fc REGION
|
EP1953173B1
(en)
|
1999-06-15 |
2009-11-18 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids endoding the same
|
CN101518653B
(zh)
|
1999-06-25 |
2015-08-19 |
基因技术股份有限公司 |
使用抗ErbB抗体-类美坦素偶联物的治疗方法
|
AU783767B2
(en)
|
1999-10-14 |
2005-12-01 |
Takara Bio Usa, Inc. |
Anthozoa derived chromophores/fluorophores and methods for using the same
|
EP1666494A1
(en)
|
1999-12-01 |
2006-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1897946B1
(en)
|
1999-12-23 |
2012-07-11 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
EP1248841B1
(en)
|
2000-01-10 |
2008-07-23 |
Novartis Vaccines and Diagnostics, Inc. |
Genes differentially expressed in breast cancer
|
CN101289511A
(zh)
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
EP2042597B1
(en)
|
2000-06-23 |
2014-05-07 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
CA2648048A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
EP2119773A1
(en)
|
2000-06-26 |
2009-11-18 |
Novozymes A/S |
Lipolytic enzymes from strains of fusarium and acremonium
|
DK1303293T3
(da)
|
2000-07-27 |
2009-03-30 |
Genentech Inc |
Sekventiel indgivelse af CPT-11 og APO-2L-polypeptid
|
ATE412009T1
(de)
|
2000-08-24 |
2008-11-15 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
CA2419577A1
(en)
|
2000-09-05 |
2002-03-14 |
Novozymes A/S |
Manganese lipoxygenase
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
FI120310B
(fi)
|
2001-02-13 |
2009-09-15 |
Valtion Teknillinen |
Parannettu menetelmä erittyvien proteiinien tuottamiseksi sienissä
|
CN100567487C
(zh)
|
2001-03-22 |
2009-12-09 |
诺沃挪第克健康护理股份公司 |
凝血因子vii衍生物
|
AU2002258728A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
AU2002305151A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
ATE452969T1
(de)
|
2001-04-20 |
2010-01-15 |
Novozymes As |
Lipoxygenase-varianten und ihre verwendung
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
PT2000545E
(pt)
|
2001-06-20 |
2011-12-21 |
Genentech Inc |
Composições e métodos para o diagnóstico e tratamento do tumor pulmonar
|
KR101008734B1
(ko)
|
2001-08-29 |
2011-01-14 |
제넨테크, 인크. |
유사분열촉진 활성을 가진 Bv8 핵산 및 폴리펩티드
|
NZ573831A
(en)
|
2001-09-18 |
2010-07-30 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor, particularly breast tumor - TAT193
|
PL368619A1
(en)
|
2001-09-27 |
2005-04-04 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
ES2411007T3
(es)
|
2001-10-10 |
2013-07-04 |
Novo Nordisk A/S |
Remodelación y glicoconjugación de péptidos
|
EP2305311A3
(en)
|
2001-10-10 |
2011-07-20 |
BioGeneriX AG |
Glycoconjugation of peptides
|
WO2003054158A2
(en)
|
2001-12-19 |
2003-07-03 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
CA2471431A1
(en)
|
2002-01-02 |
2003-07-17 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
JP2005535290A
(ja)
|
2002-02-22 |
2005-11-24 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための組成物と方法
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
NZ535925A
(en)
|
2002-04-16 |
2008-06-30 |
Genentech Inc |
An isolated antibody that binds to a particular polypeptide
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
AU2003243400B2
(en)
|
2002-06-07 |
2009-10-29 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
ES2376165T3
(es)
|
2002-07-15 |
2012-03-09 |
F. Hoffmann-La Roche Ag |
Tratamiento del c�?ncer con el anticuerpo dirigido contra erbb2 rhumab 2c4.
|
CA2497334A1
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
ES2357505T3
(es)
|
2002-09-11 |
2011-04-27 |
Genentech, Inc. |
Composición y procedimientos novedosos para el tratamiento de enfermedades inmunorelacionadas.
|
EP1543038B2
(en)
|
2002-09-11 |
2020-08-05 |
Genentech, Inc. |
Protein purification
|
WO2004024097A2
(en)
|
2002-09-16 |
2004-03-25 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
WO2004028479A2
(en)
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Nouvelles compositions et methodes de traitement du psoriasis
|
CA2503330A1
(en)
|
2002-10-29 |
2004-05-13 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
AU2003295401B2
(en)
|
2002-11-08 |
2010-04-29 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
EP2311870A1
(en)
|
2002-11-26 |
2011-04-20 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
ES2347241T3
(es)
|
2002-12-16 |
2010-10-27 |
Genentech, Inc. |
Variantes de inmunoglobulina y sus utilizaciones.
|
EP1585768A2
(en)
|
2003-01-23 |
2005-10-19 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
EP2526960A1
(en)
|
2003-03-12 |
2012-11-28 |
Genentech, Inc. |
Use of BV8 and/or EG-VEGF to promote hematopoiesis
|
LT2335725T
(lt)
|
2003-04-04 |
2017-01-25 |
Genentech, Inc. |
Didelės koncentracijos antikūno ir baltymo kompozicijos
|
CA2522345A1
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
MXPA05011421A
(es)
|
2003-04-28 |
2006-05-31 |
Novozymes As |
Fosfolipasa y metodo para producirla.
|
CN1829741A
(zh)
|
2003-05-30 |
2006-09-06 |
健泰科生物技术公司 |
利用抗-vegf抗体的治疗
|
EA008831B1
(ru)
|
2003-06-12 |
2007-08-31 |
Эли Лилли Энд Компани |
Слитые белки аналогов glp-1
|
EP2277908A3
(en)
|
2003-07-08 |
2011-12-14 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides, antibodies and therapeutic uses thereof
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
CN101870729A
(zh)
|
2003-09-09 |
2010-10-27 |
诺和诺德医疗保健公司 |
凝固因子ⅶ多肽
|
DK2161283T3
(da)
|
2003-11-17 |
2014-09-01 |
Genentech Inc |
SAMMENSÆTNINGER OMFATTENDE ANTISTOFFER MOD CD79b, SOM ER KONJUGERET TIL ET VÆKSTINHIBERENDE MIDDEL ELLER ET CYTOTOKSISK MIDDEL, OG FREMGANGSMÅDER TIL BEHANDLING AF TUMOR AF HÆMATOPOIETISK OPRINDELSE
|
AU2004293789B2
(en)
|
2003-11-21 |
2009-07-23 |
Genencor International, Inc. |
Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates
|
EP1704166B1
(en)
|
2004-01-07 |
2015-04-29 |
Novartis Vaccines and Diagnostics, Inc. |
M-csf-specific monoclonal antibody and uses thereof
|
AU2005209926B2
(en)
|
2004-02-02 |
2007-09-06 |
Ambrx, Inc. |
Modified human four helical bundle polypeptides and their uses
|
JP5114194B2
(ja)
|
2004-03-25 |
2013-01-09 |
ジェネンコー・インターナショナル・インク |
セルラーゼ融合タンパク質及びこれをコードする異種セルラーゼ融合構築体
|
US8097445B2
(en)
|
2004-03-25 |
2012-01-17 |
Danisco Us Inc. |
Exo-endo cellulase fusion protein
|
EP1736541B1
(en)
|
2004-03-29 |
2013-01-23 |
Galpharma Co., Ltd. |
Novel modified galectin 9 protein and use thereof
|
RU2429245C2
(ru)
|
2004-03-30 |
2011-09-20 |
Глаксо Груп Лимитед |
Иммуноглобулины
|
WO2005100387A1
(en)
|
2004-04-07 |
2005-10-27 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
US20150017671A1
(en)
|
2004-04-16 |
2015-01-15 |
Yaping Shou |
Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
|
US7413887B2
(en)
|
2004-05-27 |
2008-08-19 |
Genecor International, Inc. |
Trichoderma reesei glucoamylase and homologs thereof
|
US20080199927A1
(en)
|
2004-05-27 |
2008-08-21 |
Nigel Dunn-Coleman |
Aspergillus Kawachi Acid-Stable Alpha Amylase and Applications in Granular Starch Hydrolysis
|
MXPA06013599A
(es)
|
2004-05-27 |
2007-03-15 |
Genencor Int |
Expresion heterologa de una alfa amilasa estable en condiciones acidas de aspergillus kawachi y aplicaciones en la hidrolisis del almidon granular.
|
US7332319B2
(en)
|
2004-05-27 |
2008-02-19 |
Genencor International, Inc. |
Heterologous alpha amylase expression in Aspergillus
|
EP1771205B1
(en)
|
2004-06-18 |
2016-10-26 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
NZ552956A
(en)
|
2004-07-20 |
2010-03-26 |
Genentech Inc |
Inhibitors of angiopoietin-like 4 protein (ANGPTL4), combinations, and their use for treating cancer
|
FI118339B
(fi)
|
2004-09-21 |
2007-10-15 |
Ab Enzymes Oy |
Uusi lakkaasientsyymi ja sen käyttö
|
CA2586313C
(en)
|
2004-11-10 |
2016-03-08 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
EP2284191A3
(en)
|
2004-12-22 |
2011-07-20 |
Ambrx, Inc. |
Process for the preparation of hGH
|
US7638491B2
(en)
|
2004-12-22 |
2009-12-29 |
Ambrx, Inc. |
Therapies using non-natural amino acids and polypeptides
|
EP2230517A1
(en)
|
2005-01-07 |
2010-09-22 |
Diadexus, Inc. |
OVR110 antibody compositions and methods of use
|
ZA200706858B
(en)
|
2005-02-18 |
2008-10-29 |
Genencor Int |
Polypeptides having alpha-amylase and granular starch hydrolyzing activity
|
KR101447897B1
(ko)
|
2005-03-21 |
2014-10-07 |
비로베이, 인코포레이티드 |
시스테인 단백질분해효소 억제제로서의 알파 케토아미드화합물
|
DK2123746T3
(en)
|
2005-04-12 |
2017-02-27 |
Danisco Us Inc |
GEN-INACTIVATED MUTANTS WITH CHANGED PROTEIN PRODUCTION
|
US7741093B2
(en)
|
2005-04-29 |
2010-06-22 |
Ab Enzymes Oy |
Cellulases and their uses
|
US20070054360A1
(en)
|
2005-05-12 |
2007-03-08 |
Zeren Gao |
Compositions and methods for modulating immune responses
|
WO2006132788A2
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
EP1922410A2
(en)
|
2005-08-15 |
2008-05-21 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
JP5690047B2
(ja)
|
2005-09-14 |
2015-03-25 |
ノボ ノルディスク ヘルス ケア アーゲー |
ヒト凝固第vii因子ポリペプチド
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US7749704B2
(en)
|
2005-11-01 |
2010-07-06 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the BLyS gene and use in diagnostic methods
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
WO2007059312A2
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
KR101442266B1
(ko)
|
2005-11-18 |
2014-11-04 |
그렌마크 파머수티칼스 에스. 아. |
항-알파2 인테그린 항체 및 이의 용도
|
EP1962584A2
(en)
|
2005-11-21 |
2008-09-03 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
GB0525662D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Immunoglobulins
|
US7256032B2
(en)
|
2005-12-22 |
2007-08-14 |
Ab Enzymes Oy |
Enzymes
|
MX2008008225A
(es)
|
2005-12-22 |
2008-10-01 |
Ab Enzymes Oy |
Nuevas enzimas.
|
JP2009527227A
(ja)
|
2006-02-17 |
2009-07-30 |
ジェネンテック・インコーポレーテッド |
遺伝子破壊、それに関連する組成物および方法
|
AU2007227224A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
NZ596517A
(en)
|
2006-04-05 |
2013-06-28 |
Abbott Biotech Ltd |
Antibody purification
|
EP2007428A2
(en)
|
2006-04-05 |
2008-12-31 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
US7361487B2
(en)
|
2006-04-13 |
2008-04-22 |
Ab Enzymes Oy |
Enzyme fusion proteins and their use
|
JP2009536022A
(ja)
|
2006-04-19 |
2009-10-08 |
ジェネンテック・インコーポレーテッド |
新規の遺伝子破壊、それに関連する組成物および方法
|
EP2027291A2
(en)
|
2006-04-27 |
2009-02-25 |
Pikamab, Inc. |
Methods and compositions for antibody therapy
|
JP2009537147A
(ja)
|
2006-05-15 |
2009-10-29 |
シー レーン バイオテクノロジーズ, エルエルシー |
インフルエンザウイルスに対する中和抗体
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
WO2007149567A2
(en)
|
2006-06-21 |
2007-12-27 |
Musc Foundation For Research Development |
Targeting complement factor h for treatment of diseases
|
JP5829004B2
(ja)
|
2006-06-30 |
2015-12-09 |
ノボ・ノルデイスク・エー/エス |
抗nkg2a抗体とその使用
|
US20080026376A1
(en)
|
2006-07-11 |
2008-01-31 |
Huaming Wang |
KEX2 cleavage regions of recombinant fusion proteins
|
JP5517619B2
(ja)
|
2006-08-18 |
2014-06-11 |
ノバルティス アーゲー |
Prlr特異的抗体およびその使用
|
AU2007292903B2
(en)
|
2006-09-08 |
2012-03-29 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
CN101522893B
(zh)
|
2006-10-10 |
2014-07-09 |
丹尼斯科美国公司 |
具有改变性质的葡糖淀粉酶变体
|
US8444970B2
(en)
|
2006-10-27 |
2013-05-21 |
Lpath, Inc. |
Compositions and methods for treating ocular diseases and conditions
|
US7829674B2
(en)
|
2006-10-27 |
2010-11-09 |
Lpath, Inc. |
Compositions and methods for binding sphingosine-1-phosphate
|
SG176476A1
(en)
|
2006-11-02 |
2011-12-29 |
Daniel J Capon |
Hybrid immunoglobulins with moving parts
|
KR20090082480A
(ko)
|
2006-11-14 |
2009-07-30 |
제넨테크, 인크. |
뉴런 재생의 조절인자
|
US8470332B2
(en)
|
2006-11-22 |
2013-06-25 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
|
AU2007325283B2
(en)
|
2006-11-27 |
2012-08-30 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
KR101519672B1
(ko)
|
2006-12-07 |
2015-05-29 |
노파르티스 아게 |
Ephb3에 대한 길항제 항체
|
ES2426158T3
(es)
|
2007-01-22 |
2013-10-21 |
Genentech, Inc. |
Precipitación con polielectrolito y purificación de anticuerpos
|
US20100144599A1
(en)
|
2007-02-02 |
2010-06-10 |
Bristol-Myers Squibb Company |
Vegf pathway blockade
|
US8143046B2
(en)
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
US20080220498A1
(en)
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
EP2436781B1
(en)
|
2007-02-22 |
2015-10-07 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
CA2680794A1
(en)
|
2007-03-14 |
2008-09-18 |
Danisco Us Inc. |
Trichoderma reesei .alpha.-amylase enhances saccharification of corn starch
|
BRPI0809583B1
(pt)
|
2007-03-30 |
2022-02-22 |
Ambrx, Inc |
Polipeptídeo fgf-21 modificado, composição compreendendo o mesmo, método para produzir o referido polipetídeo fgf-21 e célula compreendendo um polinucleotídeo
|
US8093016B2
(en)
|
2007-05-21 |
2012-01-10 |
Danisco Us Inc. |
Use of an aspartic protease (NS24) signal sequence for heterologous protein expression
|
US9163091B2
(en)
|
2007-05-30 |
2015-10-20 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
DK2164992T3
(en)
|
2007-05-30 |
2016-08-15 |
Lpath Inc |
COMPOSITIONS AND METHODS FOR BONDING OF LYTHOPHOSPHATIC ACID
|
KR20170023212A
(ko)
|
2007-06-07 |
2017-03-02 |
제넨테크, 인크. |
보체-관련 장애의 예방 및 치료를 위한 C3b 항체 및 방법
|
JP5687057B2
(ja)
|
2007-07-09 |
2015-03-18 |
ジェネンテック, インコーポレイテッド |
ポリペプチドの組換え生産中におけるジスルフィド結合還元の防止
|
KR101486615B1
(ko)
|
2007-07-16 |
2015-01-28 |
제넨테크, 인크. |
항-cd79b 항체 및 면역접합체 및 사용 방법
|
ES2528922T3
(es)
|
2007-07-16 |
2015-02-13 |
Genentech, Inc. |
Anticuerpos anti-CD79b humanizados e inmunoconjugados y métodos de uso
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
WO2009031992A1
(en)
*
|
2007-09-04 |
2009-03-12 |
Elizabeth Varriano-Marston |
Method for controlling banana quality by packaging
|
WO2009035500A1
(en)
|
2007-09-12 |
2009-03-19 |
Danisco Us Inc., Genencor Division |
Trichoderma promoter
|
US7858759B2
(en)
|
2007-10-04 |
2010-12-28 |
Zymogenetics, Inc. |
Anti-zB7H6 antibody-drug conjugates
|
EP2479264B1
(en)
|
2007-10-09 |
2014-06-18 |
Danisco US Inc. |
Glucoamylase variants with altered properties
|
US8592194B2
(en)
|
2007-10-09 |
2013-11-26 |
Danisco Us Inc. |
Glucoamylase variants with altered properties
|
US8361465B2
(en)
|
2007-10-26 |
2013-01-29 |
Lpath, Inc. |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
|
KR20140015166A
(ko)
|
2007-10-30 |
2014-02-06 |
제넨테크, 인크. |
양이온 교환 크로마토그래피에 의한 항체 정제
|
WO2009059305A2
(en)
|
2007-11-01 |
2009-05-07 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
EP2209807A1
(en)
|
2007-11-08 |
2010-07-28 |
Genentech, Inc. |
Anti-factor b antibodies and their uses
|
KR20100097691A
(ko)
|
2007-11-12 |
2010-09-03 |
테라클론 사이언시스, 아이엔씨. |
인플루엔자의 치료 및 진단을 위한 조성물 및 방법
|
WO2009067218A2
(en)
|
2007-11-20 |
2009-05-28 |
Danisco Us Inc., Genencor Division |
Glucoamylase variants with altered properties
|
US8946148B2
(en)
|
2007-11-20 |
2015-02-03 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
WO2009073511A2
(en)
|
2007-11-30 |
2009-06-11 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the blys gene and use in diagnostic methods
|
TWI468417B
(zh)
|
2007-11-30 |
2015-01-11 |
Genentech Inc |
抗-vegf抗體
|
RU2545699C2
(ru)
|
2007-12-13 |
2015-04-10 |
ДАНИСКО ЮЭс ИНК. |
Композиции и способы получения изопрена
|
WO2009088465A2
(en)
|
2008-01-02 |
2009-07-16 |
Danisco Us Inc., Genencor Division |
A process of obtaining ethanol without glucoamylase using pseudomonas saccharophila g4-amylase and variants thereof
|
AR070141A1
(es)
|
2008-01-23 |
2010-03-17 |
Glenmark Pharmaceuticals Sa |
Anticuerpos humanizados especificos para el factor von willebrand
|
BRPI0908508A2
(pt)
|
2008-01-24 |
2016-03-22 |
Novo Nordisk As |
anticorpo monoclonal nkg2a anti-humano humanizado
|
TWI607019B
(zh)
|
2008-01-31 |
2017-12-01 |
建南德克公司 |
抗-cd79b抗體及免疫共軛物及使用方法
|
CN101939443B
(zh)
|
2008-02-08 |
2014-01-29 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
WO2009102755A1
(en)
|
2008-02-11 |
2009-08-20 |
Danisco Us Inc., Genencor Division |
Enzyme with microbial lysis activity from trichoderma reesei
|
ES2542308T3
(es)
|
2008-03-10 |
2015-08-04 |
Theraclone Sciences, Inc. |
Composiciones y métodos para la terapia y diagnóstico de infecciones por citomegalovirus
|
EP2698380A1
(en)
|
2008-03-28 |
2014-02-19 |
Sea Lane Biotechnologies, LLC |
Neutralizing molecules to viral antigens
|
CA3179151A1
(en)
|
2008-04-09 |
2009-10-15 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
HUE052318T2
(hu)
|
2008-04-18 |
2021-04-28 |
Danisco Us Inc |
Bittiauxella sp. fitáz változatok
|
SG192545A1
(en)
|
2008-04-23 |
2013-08-30 |
Danisco Us Inc |
Isoprene synthase variants for improved microbial production of isoprene
|
RU2553517C2
(ru)
|
2008-05-06 |
2015-06-20 |
Дженентек, Инк. |
Варианты crig с созревшей аффинностью
|
US8420360B2
(en)
|
2008-07-02 |
2013-04-16 |
Danisco Us Inc. |
Compositions and methods for producing isoprene free of C5 hydrocarbons under decoupling conditions and/or safe operating ranges
|
UA118536C2
(uk)
|
2008-07-23 |
2019-02-11 |
Амбркс, Інк. |
Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування
|
ES2749190T3
(es)
|
2008-08-14 |
2020-03-19 |
Genentech Inc |
Métodos para eliminar un contaminante usando cromatografía de membrana de intercambio iónico de desplazamiento de proteínas indígenas
|
PE20100269A1
(es)
|
2008-09-05 |
2010-04-30 |
TransAlgae Ltd |
Resistencia a herbicida para mantener cultivos axenicos por manipulacion genetica
|
BRPI0918936A2
(pt)
|
2008-09-15 |
2019-09-24 |
Danisco Us Inc |
conversão de derivados de prenila em isopreno
|
WO2010031062A1
(en)
|
2008-09-15 |
2010-03-18 |
Danisco Us Inc. |
Increased isoprene production using the archaeal lower mevalonate pathway
|
CA2737223A1
(en)
|
2008-09-15 |
2010-03-18 |
Danisco Us Inc. |
Reduction of carbon dioxide emission during isoprene production by fermentation
|
CA2737236A1
(en)
|
2008-09-15 |
2010-03-18 |
Danisco Us Inc. |
Systems using cell culture for production of isoprene
|
WO2010034015A2
(en)
|
2008-09-22 |
2010-03-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Modulating the alternative complement pathway
|
BRPI0919403A2
(pt)
|
2008-09-26 |
2017-09-26 |
Ambrx Inc |
polipeptídeos modificados de eritropoetina animal e seus usos
|
ES2660000T3
(es)
|
2008-09-26 |
2018-03-20 |
Ambrx, Inc. |
Vacunas y microorganismos dependientes de la replicación de aminoácidos no naturales
|
BRPI0920027A2
(pt)
|
2008-10-20 |
2015-10-06 |
Abbott Lab |
isolamento e purificação de anticorpos usando cromatografia de afinidade a proteína a
|
KR20110081862A
(ko)
|
2008-10-22 |
2011-07-14 |
제넨테크, 인크. |
축삭 변성의 조절
|
US8871202B2
(en)
|
2008-10-24 |
2014-10-28 |
Lpath, Inc. |
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
|
WO2010052556A1
(en)
|
2008-11-06 |
2010-05-14 |
Glenmark Pharmaceuticals S.A. |
Treatment with anti-alpha2 integrin antibodies
|
DK2358873T4
(en)
|
2008-12-15 |
2018-05-28 |
Danisco Us Inc |
HYBRID ALPHA AMYLASER
|
UY32341A
(es)
|
2008-12-19 |
2010-07-30 |
Glaxo Group Ltd |
Proteínas de unión antígeno novedosas
|
FI20086236A0
(fi)
|
2008-12-23 |
2008-12-23 |
Valtion Teknillinen |
Heksuronihapon konversio heksarihapoksi
|
BRPI0923828A2
(pt)
|
2008-12-30 |
2019-09-24 |
Danisco Us Inc |
método de produção de isopreno e um co-produto.
|
WO2010078376A2
(en)
|
2008-12-30 |
2010-07-08 |
Ventana Medical Systems, Inc. |
Fc-specific polymer-conjugated antibodies and their diagnostic use
|
FI122029B
(fi)
|
2008-12-30 |
2011-07-29 |
Ab Enzymes Oy |
Sieniperäiset endoglukanaasit, niiden tuotto ja käyttö
|
NZ628987A
(en)
|
2009-02-03 |
2015-11-27 |
Amunix Operating Inc |
Extended recombinant polypeptides and compositions comprising same
|
SI3260136T1
(sl)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
|
BRPI1012676A2
(pt)
|
2009-04-01 |
2016-04-05 |
Genentech Inc |
anticorpos anti-fcrh5 e imunoconjugados e métodos de uso
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
US8518686B2
(en)
|
2009-04-23 |
2013-08-27 |
Danisco Us Inc. |
Three-dimensional structure of isoprene synthase and its use thereof for generating variants
|
WO2010124163A2
(en)
|
2009-04-23 |
2010-10-28 |
Theraclone Sciences, Inc. |
Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
|
FI121712B
(fi)
|
2009-04-30 |
2011-03-15 |
Ab Enzymes Oy |
Uusi sieniperäinen proteaasi ja sen käyttö
|
FI121711B
(fi)
|
2009-04-30 |
2011-03-15 |
Ab Enzymes Oy |
Sieniperäinen seriiniproteaasi ja sen käyttö
|
DK3591046T3
(da)
|
2009-05-19 |
2021-07-26 |
Dupont Nutrition Biosci Aps |
Amylasepolypeptide
|
JP2012527473A
(ja)
|
2009-05-20 |
2012-11-08 |
セラクローン サイエンシーズ, インコーポレイテッド |
インフルエンザの治療および診断のための組成物および方法
|
NZ596787A
(en)
|
2009-06-08 |
2014-03-28 |
Amunix Operating Inc |
Growth hormone polypeptides and methods of making and using same
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
TW201412988A
(zh)
|
2009-06-17 |
2014-04-01 |
Danisco Us Inc |
使用dxp及mva途徑之改良之異戊二烯製造
|
TWI434921B
(zh)
|
2009-06-17 |
2014-04-21 |
Danisco Us Inc |
從生物異戊二烯組合物製造燃料成分之方法及系統
|
FI121851B
(fi)
|
2009-07-08 |
2011-05-13 |
Ab Enzymes Oy |
Sieniperäinen proteaasi ja sen käyttö
|
WO2011008959A1
(en)
|
2009-07-15 |
2011-01-20 |
Abbott Laboratories |
Enhancement of cellular production through mechanotransduction
|
CA2767755C
(en)
|
2009-07-17 |
2021-10-12 |
Rigshospitalet |
Inhibitors of complement activation
|
US8765431B2
(en)
|
2009-07-23 |
2014-07-01 |
The Regents Of The University Of Michigan |
Method for enzymatic production of decarboxylated polyketides and fatty acids
|
US20110027275A1
(en)
|
2009-07-31 |
2011-02-03 |
Napoleone Ferrara |
Inhibition of tumor metastasis
|
CN102712915B
(zh)
|
2009-08-19 |
2014-12-10 |
丹尼斯科美国公司 |
具有改良比活和/或热稳定性的葡糖淀粉酶的组合变体
|
EP2467474A1
(en)
|
2009-08-19 |
2012-06-27 |
Danisco A/S |
Variants of glucoamylase
|
WO2011028228A1
(en)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Coagulation factor vii compositions and methods of making and using same
|
ES2787234T3
(es)
|
2009-09-01 |
2020-10-15 |
Hoffmann La Roche |
Purificación de proteínas potenciada a través de una elución de proteína A modificada
|
EP2473522B1
(en)
|
2009-09-02 |
2016-08-17 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
WO2011038301A2
(en)
|
2009-09-25 |
2011-03-31 |
Xoma Technology Ltd. |
Screening methods
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
US8535912B2
(en)
|
2009-10-15 |
2013-09-17 |
Genentech, Inc. |
Chimeric fibroblast growth factors with altered receptor specificity
|
MX341136B
(es)
|
2009-10-20 |
2016-08-09 |
Abbvie Inc |
Aislamiento y purificacion de los anticuerpos anti-il-13 al usar la cromatografia de afinidad con proteina a.
|
BR112012009257A2
(pt)
|
2009-10-22 |
2016-11-22 |
Genentech Inc |
modulação de degeneração de axônio.
|
BR112012009409A2
(pt)
|
2009-10-22 |
2017-02-21 |
Genentech Inc |
método de identificação de uma substância inibidora, molécula antagonista, ácido nucleico isolado, vetor, célula hospedeira, método para fabricar a molécula, composição, artigo de fabricação, método de inibição de uma atividade biológica, método de tratamento de uma condição patológica, método para detectar msp em uma amostra e método para detectar hepsina em uma amostra
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
US20110098862A1
(en)
|
2009-10-27 |
2011-04-28 |
ExxonMobil Research Engineering Company Law Department |
Multi-stage processes and control thereof
|
WO2011060246A2
(en)
|
2009-11-12 |
2011-05-19 |
Genentech, Inc. |
A method of promoting dendritic spine density
|
CN103755809B
(zh)
|
2009-11-30 |
2016-06-01 |
霍夫曼-拉罗奇有限公司 |
治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
|
ES2583259T3
(es)
|
2009-12-01 |
2016-09-20 |
Novo Nordisk A/S |
Nuevas liasas alfa-amidantes de peptidil alfa-hidroxiglicina
|
WO2011080050A2
(en)
|
2009-12-11 |
2011-07-07 |
Novartis Ag |
Binding molecules
|
WO2011071577A1
(en)
|
2009-12-11 |
2011-06-16 |
Genentech, Inc. |
Anti-vegf-c antibodies and methods using same
|
JP5984676B2
(ja)
|
2009-12-18 |
2016-09-06 |
シーエスエル、リミテッド |
ポリペプチドを精製する方法
|
US20110226650A1
(en)
|
2009-12-21 |
2011-09-22 |
Genentech, Inc. |
Antibody formulation
|
MX2012006980A
(es)
|
2009-12-21 |
2012-07-17 |
Ambrx Inc |
Polipeptidos de somatotropina porcina modificados y sus usos.
|
WO2011087808A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified bovine somatotropin polypeptides and their uses
|
FI122937B
(fi)
|
2009-12-30 |
2012-09-14 |
Roal Oy |
Menetelmä selluloosamateriaalin käsittelemiseksi sekä tässä käyttökelpoiset CBH II/Cel6A entsyymit
|
US8940303B2
(en)
|
2010-01-28 |
2015-01-27 |
Glaxo Group Limited |
CD127 binding proteins
|
WO2011104604A2
(en)
|
2010-02-23 |
2011-09-01 |
Glenmark Pharmaceuticals S.A. |
Anti-alpha2 integrin antibodies and their uses
|
TW201437228A
(zh)
|
2010-02-23 |
2014-10-01 |
Genentech Inc |
用於診斷及治療腫瘤之組合物及方法
|
UA108227C2
(xx)
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
EP3815708A1
(en)
|
2010-03-05 |
2021-05-05 |
Omeros Corporation |
Chimeric inhibitor molecules of complement activation
|
WO2011120993A1
(en)
|
2010-03-29 |
2011-10-06 |
Danisco A/S |
Polypeptides having transgalactosylating activity
|
LT3178851T
(lt)
|
2010-03-31 |
2020-08-10 |
Boehringer Ingelheim International Gmbh |
Anti-cd40 antikūnai
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
SG185027A1
(en)
|
2010-05-03 |
2012-11-29 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
KR20190067277A
(ko)
|
2010-05-28 |
2019-06-14 |
제넨테크, 인크. |
락테이트 데히드로게나제 및 피루베이트 데히드로게나제 키나제의 발현의 하향조절에 의한 락테이트 수준의 감소 및 폴리펩티드 생산의 증가
|
AU2011261161A1
(en)
|
2010-06-01 |
2013-01-10 |
Ludwig Institute For Cancer Research Limited |
Antibodies directed to the unprocessed receptor tyrosine kinase c-Met
|
TW201210612A
(en)
|
2010-06-03 |
2012-03-16 |
Glaxo Group Ltd |
Humanised antigen binding proteins
|
WO2011160081A1
(en)
|
2010-06-17 |
2011-12-22 |
Danisco Us Inc. |
Fuel compositions comprising isoprene derivatives
|
CA2800206C
(en)
|
2010-06-25 |
2018-06-05 |
(Inserm) Institut National De La Sante Et De La Recherche Medicale |
Methods and pharmaceutical compositions for the treatment of respiratory tract infections
|
CA2805035A1
(en)
|
2010-07-22 |
2012-01-26 |
Glaxosmithkline Biologicals S.A. |
Novel antigen binding proteins
|
CN103068997A
(zh)
|
2010-08-06 |
2013-04-24 |
丹尼斯科美国公司 |
中性pH糖化和发酵
|
EP2601300A1
(en)
|
2010-08-06 |
2013-06-12 |
Danisco US Inc. |
Production of isoprene under neutral ph conditions
|
WO2012021786A2
(en)
|
2010-08-12 |
2012-02-16 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
EP2420250A1
(en)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4 antibodies
|
EP2603525A1
(en)
|
2010-08-13 |
2013-06-19 |
F.Hoffmann-La Roche Ag |
Antibodies to il-1beta and il-18, for treatment of disease
|
BR112013003522B1
(pt)
|
2010-08-17 |
2021-05-25 |
Ambrx, Inc. |
polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, seu método de preparação e seu uso, bem como ácido nucleico e célula hospedeira
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
CN103068264A
(zh)
|
2010-08-24 |
2013-04-24 |
丹尼斯科美国公司 |
包含低温大米蛋白浓缩物的食品产品
|
PT3556396T
(pt)
|
2010-08-31 |
2022-07-04 |
Scripps Research Inst |
Anticorpos neutralizantes do vírus da imunodeficiência humana (vih)
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
AU2011302522A1
(en)
|
2010-09-15 |
2013-05-02 |
Aligna Technologies, Inc. |
Bioproduction of aromatic chemicals from lignin-derived compounds
|
AU2011305754B2
(en)
|
2010-09-20 |
2015-11-05 |
Abbvie Inc. |
Purification of antibodies using simulated moving bed chromatography
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
EP2625197B1
(en)
|
2010-10-05 |
2016-06-29 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US9632098B2
(en)
|
2010-10-08 |
2017-04-25 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin fragments and uses thereof
|
JP5913326B2
(ja)
|
2010-10-08 |
2016-04-27 |
シャンハイ クーシン バイオテック カンパニー,リミテッド |
モエシン断片の診断的および治療的使用
|
CA2814026C
(en)
|
2010-10-08 |
2017-07-11 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin fragments associated with aplastic anemia
|
EP2624854B1
(en)
|
2010-10-08 |
2016-08-03 |
Shanghai Kexin Biotech Co., Ltd |
Moesin inhibitors and uses thereof
|
JP5696220B2
(ja)
|
2010-10-08 |
2015-04-08 |
シャンハイ クーシン バイオテック カンパニー,リミテッド |
免疫性血小板減少症を診断するための測定方法及びキット、並びに診断組成物の製造におけるモエシン断片の使用
|
US9273298B2
(en)
|
2010-10-27 |
2016-03-01 |
Danisco Us Inc. |
Isoprene synthase variants for improved production of isoprene
|
FI123942B
(fi)
|
2010-10-29 |
2013-12-31 |
Ab Enzymes Oy |
Sieniperäisen seriiniproteaasin variantteja
|
MX343858B
(es)
|
2010-11-04 |
2016-11-25 |
Boehringer Ingelheim Int |
Anticuerpos anti-il-23.
|
AU2011338892A1
(en)
|
2010-11-05 |
2013-05-23 |
Abbvie Inc. |
Efficient and effective supplement screening for the development of chemically defined media in cell culture
|
US20140199682A1
(en)
|
2010-11-17 |
2014-07-17 |
Sea Lane Biotechnologies, Llc |
Influenza neutralizing agents
|
CN103429261A
(zh)
|
2010-12-22 |
2013-12-04 |
塞法隆澳大利亚股份有限公司 |
半寿期改进的修饰抗体
|
EP2655597A1
(en)
|
2010-12-22 |
2013-10-30 |
Danisco US Inc. |
Biological production of pentose sugars using recombinant cells
|
CA2822467A1
(en)
|
2010-12-22 |
2012-06-28 |
Danisco Us Inc. |
Compositions and methods for improved isoprene production using two types of ispg enzymes
|
CA2827301A1
(en)
|
2011-02-14 |
2012-08-23 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
US20140056897A1
(en)
|
2011-03-10 |
2014-02-27 |
Hco Antibody, Inc. |
Bispecific three-chain antibody-like molecules
|
WO2012122512A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Recombinant production of mixtures of single chain antibodies
|
JP2014509591A
(ja)
|
2011-03-15 |
2014-04-21 |
セラクローン サイエンシーズ, インコーポレイテッド |
インフルエンザの治療および診断のための組成物および方法
|
US20120238730A1
(en)
|
2011-03-15 |
2012-09-20 |
Abbott Laboratories |
Integrated approach to the isolation and purification of antibodies
|
WO2012128810A1
(en)
|
2011-03-23 |
2012-09-27 |
Abbott Laboratories |
Methods and systems for the analysis of protein samples
|
CN103608038A
(zh)
|
2011-03-31 |
2014-02-26 |
弗·哈夫曼-拉罗切有限公司 |
施用β7整联蛋白拮抗剂的方法
|
FI123425B
(fi)
|
2011-03-31 |
2013-04-30 |
Ab Enzymes Oy |
Proteaasientsyymi ja sen käytöt
|
US9062106B2
(en)
|
2011-04-27 |
2015-06-23 |
Abbvie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
BR112013027170A2
(pt)
|
2011-04-29 |
2017-06-20 |
Danisco Us Inc |
processo em ph único para liquefação e sacarificação de amido para xaropes de glicose de densidade alta
|
CN103842383B
(zh)
|
2011-05-16 |
2017-11-03 |
健能隆医药技术(上海)有限公司 |
多特异性fab融合蛋白及其使用方法
|
US8569462B2
(en)
|
2011-06-03 |
2013-10-29 |
Xoma Technology Ltd. |
Antibodies specific for TGF-beta and methods for treating thereof
|
JP2013040160A
(ja)
|
2011-07-01 |
2013-02-28 |
Genentech Inc |
自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
|
CA2840460C
(en)
|
2011-07-11 |
2022-08-16 |
Glenmark Pharmaceuticals S.A. |
Antibodies that bind to ox40 and their uses
|
BR112014002745A8
(pt)
|
2011-08-05 |
2017-06-20 |
Danisco Us Inc |
produção de isoprenoides sob condições de ph neutro
|
KR20140068877A
(ko)
|
2011-08-17 |
2014-06-09 |
제넨테크, 인크. |
불응성 종양에서의 혈관신생의 억제
|
US8822651B2
(en)
|
2011-08-30 |
2014-09-02 |
Theraclone Sciences, Inc. |
Human rhinovirus (HRV) antibodies
|
WO2013040093A2
(en)
|
2011-09-12 |
2013-03-21 |
Amunix Operating Inc. |
Glucagon-like peptide-2 compositions and methods of making and using same
|
WO2013041687A1
(en)
|
2011-09-23 |
2013-03-28 |
Amgen Research (Munich) Gmbh |
Bispecific binding molecules for 5t4 and cd3
|
WO2013067028A1
(en)
|
2011-10-31 |
2013-05-10 |
Bp Corporation North America Inc. |
Use of mammalian promoters in filamentous fungi
|
WO2013067026A1
(en)
|
2011-10-31 |
2013-05-10 |
Bp Corporation North America Inc. |
Use of plant promoters in filamentous fungi
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
EA031948B1
(ru)
|
2011-11-16 |
2019-03-29 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Антитело к il-36r или его антигенсвязывающий фрагмент, выделенный полинуклеотид, клетка-хозяин и способ получения этого антитела или его фрагмента, содержащая их фармацевтическая композиция и применение антитела или его фрагмента и композиции
|
ES2651521T3
(es)
|
2011-12-01 |
2018-01-26 |
Innovent Biologics, Inc. |
Inhibidores proteicos de las rutas del complemento y de VEGF y métodos de uso de los mismos
|
SG11201403276TA
(en)
|
2011-12-16 |
2014-10-30 |
Braskem Sa |
Modified microorganisms and methods of making butadiene using same
|
WO2013091903A1
(en)
|
2011-12-22 |
2013-06-27 |
Novo Nordisk A/S |
Anti-crac channel antibodies
|
AU2012355356B2
(en)
|
2011-12-22 |
2017-10-12 |
Genentech, Inc. |
Ion exchange membrane chromatography
|
WO2013109342A1
(en)
|
2012-01-19 |
2013-07-25 |
University Of Cincinnati |
Method of treating diabetes using non-glycosylated apolipoprotein a-iv
|
JP2015506950A
(ja)
|
2012-01-31 |
2015-03-05 |
ジェネンテック, インコーポレイテッド |
抗ig−em1’抗体およびそれを用いる方法
|
SG10201606195UA
(en)
|
2012-02-09 |
2016-09-29 |
Var2 Pharmaceuticals Aps |
Targeting of chondroitin sulfate glycans
|
CN104487452A
(zh)
|
2012-02-15 |
2015-04-01 |
阿穆尼克斯运营公司 |
因子viii组合物及其制备和使用方法
|
NZ628014A
(en)
|
2012-02-15 |
2016-09-30 |
Biogen Ma Inc |
Recombinant factor viii proteins
|
EP2820047B1
(en)
|
2012-03-01 |
2018-04-25 |
Amgen Research (Munich) GmbH |
Long life polypeptide binding molecules
|
WO2013158275A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Cell culture methods to reduce acidic species
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
CA2870769C
(en)
|
2012-04-27 |
2021-11-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Vascular endothelial growth factor antagonists and methods for their use
|
US9163263B2
(en)
|
2012-05-02 |
2015-10-20 |
The Goodyear Tire & Rubber Company |
Identification of isoprene synthase variants with improved properties for the production of isoprene
|
WO2013165791A1
(en)
|
2012-05-03 |
2013-11-07 |
Boehringer Ingelheim International Gmbh |
Anti-il-23p19 antibodies
|
WO2013177118A2
(en)
|
2012-05-21 |
2013-11-28 |
Abbvie Inc. |
Novel purification of non-human antibodies using protein a affinity chromatography
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
HRP20220545T1
(hr)
|
2012-06-08 |
2022-06-10 |
Dupont Nutrition Biosciences Aps |
Polipeptidi koji imaju transgalaktozilirajuću aktivnost
|
US10232019B2
(en)
|
2012-07-25 |
2019-03-19 |
University Of Cincinnati |
Method of treating hyperglycemic disorders using apolipoprotein AIV
|
CA2878695A1
(en)
|
2012-07-25 |
2014-01-30 |
University Of Cincinnati |
Method of treating type i diabetes using apolipoprotein aiv
|
MX2015002099A
(es)
|
2012-08-22 |
2015-05-11 |
Dupont Nutrition Biosci Aps |
Variantes que tienen actividad glucoamilasa.
|
JOP20200308A1
(ar)
|
2012-09-07 |
2017-06-16 |
Novartis Ag |
جزيئات إرتباط il-18
|
EP2906693A1
(en)
|
2012-10-15 |
2015-08-19 |
Novo Nordisk Health Care AG |
Coagulation factor vii polypeptides
|
WO2014106602A1
(en)
|
2013-01-02 |
2014-07-10 |
Glenmark Pharmaceuticals S.A. |
Antibodies that bind to tl1a and their uses
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
ES2728936T3
(es)
|
2013-01-25 |
2019-10-29 |
Amgen Inc |
Anticuerpos dirigidos contra CDH19 para melanoma
|
CN104968362B
(zh)
|
2013-03-13 |
2018-12-14 |
霍夫曼-拉罗奇有限公司 |
氧化降低的配制剂
|
SI2968467T1
(sl)
|
2013-03-13 |
2020-11-30 |
F. Hoffmann-La Roche Ag |
Pripravki z zmanjšano oksidacijo
|
AR095398A1
(es)
|
2013-03-13 |
2015-10-14 |
Genentech Inc |
Formulaciones con oxidación reducida
|
AR095399A1
(es)
|
2013-03-13 |
2015-10-14 |
Genentech Inc |
Formulaciones con oxidación reducida, método
|
SG10201913932VA
(en)
|
2013-03-13 |
2020-03-30 |
Genentech Inc |
Antibody formulations
|
CA2899308C
(en)
|
2013-03-14 |
2017-04-18 |
Abbvie Inc. |
Low acidic species adalimumab compositions and uses thereof
|
US20140271633A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Mammalian cell culture performance through surfactant supplementation of feed media
|
EP2970375A1
(en)
|
2013-03-14 |
2016-01-20 |
AbbVie Inc. |
Low acidic species compositions and methods for producing the same using displacement chromatography
|
WO2014142882A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Protein purification using displacement chromatography
|
AR095374A1
(es)
|
2013-03-15 |
2015-10-14 |
Amgen Res (Munich) Gmbh |
Moléculas de unión para bcma y cd3
|
KR102202476B1
(ko)
|
2013-03-15 |
2021-01-12 |
제넨테크, 인크. |
세포 배양 배지 및 항체 생산 방법
|
EP2970446A1
(en)
|
2013-03-15 |
2016-01-20 |
Amgen Research (Munich) GmbH |
Antibody constructs for influenza m2 and cd3
|
TW201525001A
(zh)
|
2013-03-15 |
2015-07-01 |
Amgen Res Munich Gmbh |
包含n-端abp之單鏈結合分子
|
BR112015021993A8
(pt)
|
2013-03-15 |
2019-12-03 |
Genentech Inc |
polipeptídeo, métodos para sua produção, métodos para cultivo de uma célula, composição farmacêutica, kit, e meio de cultura celular
|
US20140283157A1
(en)
|
2013-03-15 |
2014-09-18 |
Diadexus, Inc. |
Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
|
WO2014145768A2
(en)
|
2013-03-15 |
2014-09-18 |
Bp Corporation North America Inc. |
Use of non-fungal 5' utrs in filamentous fungi
|
EP4039281A1
(en)
|
2013-03-15 |
2022-08-10 |
Biomolecular Holdings LLC |
Hybrid immunoglobulin containing non-peptidyl linkage
|
JP6574754B2
(ja)
|
2013-03-19 |
2019-09-11 |
ベイジン シェノゲン ファーマ グループ リミテッド |
エストロゲン受容体関連疾患を処置するための抗体及び方法
|
RU2015145610A
(ru)
|
2013-03-27 |
2017-05-04 |
Дженентек, Инк. |
Применение биомаркеров для оценки лечения желудочно-кишечных воспалительных расстройств антагонистами бета7 интегрина
|
LT3004162T
(lt)
|
2013-05-31 |
2020-06-10 |
Genentech, Inc. |
Antikūnai prieš ląstelės sienelės teicho rūgštį ir konjugatai
|
EP3033097B1
(en)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Factor viii-xten fusions and uses thereof
|
TWI688401B
(zh)
|
2013-09-13 |
2020-03-21 |
美商安進公司 |
用於治療骨髓性白血病的表觀遺傳因子與靶向cd33及cd3之雙特異性化合物的組合
|
HUE047194T2
(hu)
|
2013-09-27 |
2020-04-28 |
Hoffmann La Roche |
Anti-PDL1 antitest készítmények
|
WO2015069459A1
(en)
|
2013-11-05 |
2015-05-14 |
Novartis Ag |
Organic compounds
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
EP3082456A1
(en)
|
2013-12-11 |
2016-10-26 |
DuPont Nutrition Biosciences ApS |
A method for preparing a dairy product having a stable content of galacto-oligosaccharide(s)
|
MX2016007972A
(es)
|
2013-12-17 |
2016-10-28 |
Genentech Inc |
Metodos para tratar canceres con antagonistas de union al eje pd-1 y taxanos.
|
CA2934028A1
(en)
|
2013-12-17 |
2015-06-25 |
Genentech, Inc. |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
CN105899535A
(zh)
|
2013-12-17 |
2016-08-24 |
豪夫迈·罗氏有限公司 |
用pd-1轴结合拮抗剂和抗cd20抗体治疗癌症的方法
|
CN106062005A
(zh)
|
2013-12-30 |
2016-10-26 |
医药生命融合研究团 |
抗krs单克隆抗体及其用途
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
WO2016039801A1
(en)
|
2014-01-31 |
2016-03-17 |
Boehringer Ingelheim International Gmbh |
Novel anti-baff antibodies
|
AU2015214264B2
(en)
|
2014-02-04 |
2018-12-20 |
Curis, Inc. |
Mutant Smoothened and methods of using the same
|
KR102587838B1
(ko)
|
2014-03-14 |
2023-10-12 |
바이오몰레큘러 홀딩스 엘엘씨 |
비-펩티드 결합을 함유하는 하이브리드 면역글로불린
|
CN111808276A
(zh)
|
2014-03-25 |
2020-10-23 |
豪夫迈·罗氏有限公司 |
制备用于细胞培养基中的泊洛沙姆的方法
|
EP3122377A4
(en)
|
2014-03-27 |
2018-03-14 |
F.Hoffmann-La Roche Ag |
Methods for diagnosing and treating inflammatory bowel disease
|
CN106132439A
(zh)
|
2014-03-31 |
2016-11-16 |
豪夫迈·罗氏有限公司 |
包含抗血管发生剂和ox40结合激动剂的组合疗法
|
EP3149187B1
(en)
|
2014-05-30 |
2020-04-29 |
Braskem S.A. |
Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same
|
EP3145951A1
(en)
|
2014-06-24 |
2017-03-29 |
InSight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
US20170226552A1
(en)
|
2014-07-03 |
2017-08-10 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
|
WO2016007764A1
(en)
|
2014-07-09 |
2016-01-14 |
Abbvie Inc. |
Methods for modulating the glycosylation profile of recombinant proteins using non-commonly used sugars
|
EP3708679A1
(en)
|
2014-07-24 |
2020-09-16 |
Boehringer Ingelheim International GmbH |
Biomarkers useful in the treatment of il-23a related diseases
|
JP6749312B2
(ja)
|
2014-07-31 |
2020-09-02 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH |
最適化された種間特異的二重特異性単鎖抗体コンストラクト
|
EP3174903B1
(en)
|
2014-07-31 |
2024-04-10 |
Amgen Research (Munich) GmbH |
Bispecific single chain antibody construct with enhanced tissue distribution
|
UY36245A
(es)
|
2014-07-31 |
2016-01-29 |
Amgen Res Munich Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
EP3193932B1
(en)
|
2014-09-15 |
2023-04-26 |
F. Hoffmann-La Roche AG |
Antibody formulations
|
WO2016059602A2
(en)
|
2014-10-16 |
2016-04-21 |
Glaxo Group Limited |
Methods of treating cancer and related compositions
|
US9434778B2
(en)
|
2014-10-24 |
2016-09-06 |
Bristol-Myers Squibb Company |
Modified FGF-21 polypeptides comprising an internal deletion and uses thereof
|
JP6974166B2
(ja)
|
2014-11-07 |
2021-12-01 |
デュポン ニュートリション バイオサイエンシス エーピーエス |
マンナナーゼ、セルラーゼおよびペクチナーゼが欠乏している、ベータ−ガラクトシダーゼ活性および/またはトランスガラクトシル化活性を発現する組換え宿主細胞
|
WO2016081384A1
(en)
|
2014-11-17 |
2016-05-26 |
Genentech, Inc. |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
MX2017007055A
(es)
|
2014-12-03 |
2017-11-08 |
Genentech Inc |
Conjugados de anticuerpo rifamicina anti-staphylococcus aureus y usos de estos.
|
IL307578A
(en)
|
2015-02-04 |
2023-12-01 |
Boehringer Ingelheim Int |
Methods for treating inflammatory diseases
|
JP2018512597A
(ja)
|
2015-02-04 |
2018-05-17 |
ジェネンテック, インコーポレイテッド |
突然変異体スムースンド及びその使用方法
|
US10907187B2
(en)
|
2015-02-09 |
2021-02-02 |
Danisco Us Inc |
Fungal strains and methods of use
|
EP3262072A1
(en)
|
2015-02-26 |
2018-01-03 |
F. Hoffmann-La Roche AG |
Integrin beta7 antagonists and methods of treating crohn's disease
|
US10711067B2
(en)
|
2015-03-03 |
2020-07-14 |
Xoma (Us) Llc |
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery
|
WO2016144773A1
(en)
|
2015-03-06 |
2016-09-15 |
Abbvie Inc. |
Arabinosylated glycoproteins
|
CN108136001B
(zh)
|
2015-04-03 |
2022-07-29 |
佐马技术有限公司 |
使用TGF-β抑制剂和PD-1抑制剂治疗癌症
|
EP3391905A1
(en)
|
2015-04-14 |
2018-10-24 |
Boehringer Ingelheim International GmbH |
Treatment of asthma with anti-il-23a antibodies
|
FI3283524T3
(fi)
|
2015-04-17 |
2023-05-05 |
Amgen Res Munich Gmbh |
Bispesifisiä vasta-ainekonstrukteja cdh3:lle ja cd3:lle
|
EP4155399A1
(en)
|
2015-05-22 |
2023-03-29 |
DuPont Nutrition Biosciences ApS |
Acetolactate decarboxylase
|
KR20180013881A
(ko)
|
2015-05-29 |
2018-02-07 |
제넨테크, 인크. |
암에서의 pd-l1 프로모터 메틸화
|
JP6896650B2
(ja)
|
2015-06-17 |
2021-06-30 |
ジェネンテック, インコーポレイテッド |
Pd−1軸結合アンタゴニスト及びタキサンを使用した局所進行性または転移性乳癌の治療方法
|
TW202346349A
(zh)
|
2015-07-31 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
EA201890423A1
(ru)
|
2015-08-03 |
2018-07-31 |
Биовератив Терапьютикс Инк. |
Слитые белки фактора ix, способы их получения и применения
|
TW202330904A
(zh)
|
2015-08-04 |
2023-08-01 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
CA2993276A1
(en)
|
2015-08-11 |
2017-02-16 |
Yong Zheng |
Novel anti-pd-1 antibodies
|
MX2018002617A
(es)
|
2015-09-02 |
2018-07-06 |
Dupont Nutrition Biosci Aps |
Glucosido hidrolasas y su uso en la prevencion y/o tratamiento de infeccion patogena en un animal.
|
US20190248905A1
(en)
|
2015-09-07 |
2019-08-15 |
Helmholtz Zentrum Muenchen-Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
Novel igfr-like receptor and uses thereof
|
TWI733695B
(zh)
|
2015-09-18 |
2021-07-21 |
德商百靈佳殷格翰國際股份有限公司 |
治療發炎性疾病之方法
|
JP7008023B2
(ja)
|
2015-12-30 |
2022-01-25 |
ジェネンテック, インコーポレイテッド |
低減されたポリソルベート分解を有する製剤
|
MX2018008063A
(es)
|
2015-12-30 |
2018-11-29 |
Genentech Inc |
Uso de derivados de triptofano para formulaciones de proteina.
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
RS62841B1
(sr)
|
2016-02-03 |
2022-02-28 |
Amgen Res Munich Gmbh |
Bcma i cd3 konstrukti antitela koji angažuju bispecifične t ćelije
|
AU2017216237B2
(en)
|
2016-02-03 |
2024-04-04 |
Amgen Research (Munich) Gmbh |
PSMA and CD3 bispecific T cell engaging antibody constructs
|
EP3411396A1
(en)
|
2016-02-04 |
2018-12-12 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
CN116196412A
(zh)
|
2016-03-15 |
2023-06-02 |
中外制药株式会社 |
使用pd-1轴结合拮抗剂和抗gpc3抗体治疗癌症的方法
|
CA3017776A1
(en)
|
2016-03-15 |
2017-09-21 |
Generon (Shanghai) Corporation Ltd. |
Multispecific fab fusion proteins and use thereof
|
WO2017161976A1
(en)
|
2016-03-23 |
2017-09-28 |
Mabspace Biosciences (Suzhou) Co., Ltd |
Novel anti-pd-l1 antibodies
|
ES2930351T3
(es)
|
2016-04-15 |
2022-12-09 |
Evive Biotechnology Shanghai Ltd |
Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante
|
JP6728392B2
(ja)
|
2016-04-15 |
2020-07-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
炎症性疾患の処置法
|
EP3464354B1
(en)
|
2016-06-02 |
2021-07-28 |
Bloom Diagnostics AG |
Antibodies that bind to human anti-müllerian hormone (amh) and their uses
|
DK3478831T3
(da)
|
2016-06-30 |
2021-04-19 |
Danisco Us Inc |
Asparaginproteaser
|
US10519250B2
(en)
|
2016-08-01 |
2019-12-31 |
Xoma (Us) Llc |
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof
|
EP3497129A1
(en)
|
2016-08-08 |
2019-06-19 |
H. Hoffnabb-La Roche Ag |
Therapeutic and diagnostic methods for cancer
|
CN109963942A
(zh)
|
2016-09-16 |
2019-07-02 |
杜邦营养生物科学有限公司 |
具有改善的比活性的乙酰乳酸脱羧酶变体
|
US11111313B2
(en)
|
2016-09-20 |
2021-09-07 |
WuXi Biologics Ireland Limited |
Anti-PCSK9 antibodies
|
EP3515205A1
(en)
|
2016-09-23 |
2019-07-31 |
DuPont Nutrition Biosciences ApS |
Use of low ph active alpha-1,4/1,6-glycoside hydrolases as a feed additive for ruminants to enhance starch digestion
|
CA3038679A1
(en)
|
2016-09-28 |
2018-04-05 |
Xoma (Us) Llc |
Antibodies that bind interleukin-2 and uses thereof
|
WO2018067599A1
(en)
|
2016-10-04 |
2018-04-12 |
Danisco Us Inc. |
Protein production in filamentous fungal cells in the absence of inducing substrates
|
EP3526252A2
(en)
|
2016-10-14 |
2019-08-21 |
Boehringer Ingelheim International GmbH |
Methods of treating diseases with il-23a antibody
|
EP3526248A4
(en)
|
2016-10-17 |
2020-07-08 |
Musc Foundation for Research Development |
COMPOSITIONS AND METHODS FOR TREATING LESIONS OF THE CENTRAL VENEER SYSTEM
|
WO2018093752A1
(en)
|
2016-11-15 |
2018-05-24 |
Danisco Us Inc. |
Filamentous fungi with improved protein production
|
EP3574007A1
(en)
|
2017-01-30 |
2019-12-04 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel igfr-like 2 receptor and uses thereof
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
TW201837051A
(zh)
|
2017-02-08 |
2018-10-16 |
美商必治妥美雅史谷比公司 |
包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
BR112019018381A2
(pt)
|
2017-03-06 |
2020-04-07 |
Dupont Nutrition Biosci Aps |
fucosidases fúngicas e seu uso na prevenção e/ou no tratamento de uma infecção patogênica em um animal
|
JP7216424B2
(ja)
|
2017-03-15 |
2023-02-01 |
チンファ ユニバーシティ |
新規の抗TrkB抗体
|
EP3601350A1
(en)
|
2017-03-27 |
2020-02-05 |
Boehringer Ingelheim International GmbH |
Anti il-36r antibodies combination therapy
|
WO2018182284A1
(ko)
|
2017-03-27 |
2018-10-04 |
재단법인 의약바이오컨버젼스연구단 |
세포 외막에 노출되는 라이실-tRNA 합성효소 N-말단 영역에 특이적으로 결합하는 항체
|
EP4230649A3
(en)
|
2017-04-25 |
2023-10-25 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
BR112019022751A2
(pt)
|
2017-05-05 |
2020-05-19 |
Amgen Inc |
composição farmacêutica compreendendo construtos de anticorpos biespecíficos para armazenamento e administração melhorados
|
US10793634B2
(en)
|
2017-06-09 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Anti-TrkB antibodies
|
WO2019018629A1
(en)
|
2017-07-19 |
2019-01-24 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
ANTIBODIES AND METHODS FOR DIAGNOSING AND TREATING INFECTION WITH HEPATITIS B VIRUS
|
WO2019089544A1
(en)
|
2017-11-01 |
2019-05-09 |
Tufts Medical Center, Inc. |
Bispecific antibody constructs and methods of use
|
TWI827570B
(zh)
|
2017-12-11 |
2024-01-01 |
美商安進公司 |
雙特異性抗體產品之連續製造製程
|
TW201940518A
(zh)
|
2017-12-29 |
2019-10-16 |
美商安進公司 |
針對muc17和cd3之雙特異性抗體構建體
|
JP2021514193A
(ja)
|
2018-02-21 |
2021-06-10 |
セルジーン コーポレイション |
Bcma結合抗体及びその使用
|
KR102340989B1
(ko)
|
2018-03-28 |
2021-12-20 |
에이비온 주식회사 |
클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도
|
CN112334485A
(zh)
|
2018-04-06 |
2021-02-05 |
百进生物科技公司 |
抗-四次穿膜蛋白33药剂及其组合物以及制备和使用方法
|
US20210171610A1
(en)
|
2018-05-02 |
2021-06-10 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
TWI819011B
(zh)
|
2018-06-23 |
2023-10-21 |
美商建南德克公司 |
以pd-1 軸結合拮抗劑、鉑劑及拓撲異構酶ii 抑制劑治療肺癌之方法
|
KR20210027436A
(ko)
|
2018-06-29 |
2021-03-10 |
베링거 인겔하임 인터내셔날 게엠베하 |
자가면역 질환을 치료하는데 사용하기 위한 항-cd40 항체
|
US20210278406A1
(en)
|
2018-07-13 |
2021-09-09 |
Varct Diagnostic Aps |
Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
|
JP2021533149A
(ja)
|
2018-08-08 |
2021-12-02 |
ジェネンテック, インコーポレイテッド |
タンパク質製剤のためのトリプトファン誘導体及びl−メチオニンの使用
|
EP3857230B1
(en)
|
2018-09-21 |
2023-06-07 |
F. Hoffmann-La Roche AG |
Diagnostic methods for triple-negative breast cancer
|
WO2020068557A1
(en)
|
2018-09-25 |
2020-04-02 |
BioLegend, Inc. |
Anti-tlr9 agents and compositions and methods for making and using the same
|
WO2020069303A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Antibodies against soluble bcma
|
WO2020077212A1
(en)
|
2018-10-11 |
2020-04-16 |
Amgen Inc. |
Downstream processing of bispecific antibody constructs
|
WO2020083979A1
(en)
|
2018-10-23 |
2020-04-30 |
Glycardial Diagnostics, S.L. |
Antibodies specific for glycosylated apoj and uses thereof
|
CN114096559A
(zh)
|
2019-03-27 |
2022-02-25 |
蒂嘉特克斯公司 |
工程化iga抗体及其使用方法
|
EA202193038A1
(ru)
|
2019-05-09 |
2022-03-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Антитела против sema3a и их применения для лечения заболеваний глаз
|
TW202108627A
(zh)
|
2019-05-24 |
2021-03-01 |
大陸商三優生物醫藥(上海)有限公司 |
新型cldn18.2結合分子
|
AU2020290573A1
(en)
|
2019-06-13 |
2021-11-04 |
Amgen Inc. |
Automated biomass-based perfusion control in the manufacturing of biologics
|
TW202115112A
(zh)
|
2019-06-27 |
2021-04-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-angpt2抗體
|
JP7302093B2
(ja)
|
2019-07-18 |
2023-07-03 |
ジェイダブリュ バイオサイエンス |
Wrsタンパク質に特異的に結合する抗体及びその用途
|
MX2022002337A
(es)
|
2019-08-27 |
2022-06-08 |
Tonix Pharma Ltd |
Polipéptidos de tff2 modificados.
|
EP4028416A1
(en)
|
2019-09-10 |
2022-07-20 |
Amgen Inc. |
Purification method for bispecific antigen-binding polypeptides with enhanced protein l capture dynamic binding capacity
|
US20230125690A1
(en)
|
2019-09-20 |
2023-04-27 |
Jae-sung Bae |
Antibody for detecting acetylation of cox2 protein, and uses thereof
|
TW202126685A
(zh)
|
2019-09-24 |
2021-07-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗nrp1a抗體及其用於治療眼或眼部疾病之用途
|
CA3156683A1
(en)
|
2019-11-13 |
2021-05-20 |
Amgen Inc. |
METHOD FOR REDUCING AGGREGATE FORMATION IN DOWNSTREAM PROCESSING OF BI-SPECIFIC ANTIGEN-BINDING MOLECULES
|
EP4077699A1
(en)
|
2019-12-19 |
2022-10-26 |
Basf Se |
Increasing space-time-yield, carbon-conversion-efficiency and carbon substrate flexibility in the production of fine chemicals
|
JP2023508871A
(ja)
|
2019-12-20 |
2023-03-06 |
ビーエーエスエフ ソシエタス・ヨーロピア |
テルペンの毒性の低減および微生物中での生成可能性の増大
|
US20230093169A1
(en)
|
2020-01-22 |
2023-03-23 |
Amgen Research (Munch) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
CN113461817A
(zh)
|
2020-03-31 |
2021-10-01 |
苏州泽璟生物制药股份有限公司 |
一种抗人cd47抗体及其抗原结合片段、制备方法和应用
|
TW202204601A
(zh)
|
2020-04-15 |
2022-02-01 |
美商建南德克公司 |
銅損失減緩
|
US20210380696A1
(en)
|
2020-05-26 |
2021-12-09 |
Boehringer Ingelheim International Gmbh |
Anti-pd-1 antibodies
|
EP4157875A1
(en)
|
2020-06-02 |
2023-04-05 |
Arcus Biosciences, Inc. |
Antibodies to tigit
|
US20210388064A1
(en)
|
2020-06-15 |
2021-12-16 |
Sarepta Therapeutics, Inc. |
Adeno-associated virus antibodies and fragments thereof
|
CN115916182A
(zh)
|
2020-06-16 |
2023-04-04 |
基因泰克公司 |
用于治疗三阴性乳腺癌的方法和组合物
|
EP3939999A1
(en)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
|
WO2022093641A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2a agents and compositions and methods for making and using the same
|
WO2022093640A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2c agents and compositions and methods for making and using the same
|
TW202233678A
(zh)
|
2020-11-06 |
2022-09-01 |
德商安美基研究(慕尼黑)公司 |
具有增強的剪切特徵的多肽
|
CR20230235A
(es)
|
2020-11-06 |
2023-10-05 |
Amgen Res Munich Gmbh |
Construcciones polipeptídicas que se unen selectivamente a cldn6 y cd3
|
WO2022096698A1
(en)
|
2020-11-06 |
2022-05-12 |
Amgen Inc. |
Polypeptide constructs binding to cd3
|
CN112480248B
(zh)
|
2020-11-24 |
2023-05-05 |
三优生物医药(上海)有限公司 |
与cld18a2特异性结合的分子
|
EP4263597A2
(en)
|
2020-12-18 |
2023-10-25 |
Kiniksa Pharmaceuticals, Ltd. |
Protein compositions and methods for producing and using the same
|
AU2022246675A1
(en)
|
2021-04-02 |
2023-10-19 |
Amgen Inc. |
Mageb2 binding constructs
|
AU2022313524A1
(en)
|
2021-07-23 |
2024-02-15 |
Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
Igfr-l1 antibodies and uses thereof
|
WO2023105087A1
(en)
|
2021-12-10 |
2023-06-15 |
Tubulis Gmbh |
Novel flt3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitors
|
EP4238988A1
(en)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Antibodies against sars-cov-2 and uses thereof
|
WO2023173011A1
(en)
|
2022-03-09 |
2023-09-14 |
Bristol-Myers Squibb Company |
Transient expression of therapeutic proteins
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|